ES8605374A1 - Un metodo de produccion de una solucion inyectable de un antraciclina glicosido - Google Patents

Un metodo de produccion de una solucion inyectable de un antraciclina glicosido

Info

Publication number
ES8605374A1
ES8605374A1 ES547578A ES547578A ES8605374A1 ES 8605374 A1 ES8605374 A1 ES 8605374A1 ES 547578 A ES547578 A ES 547578A ES 547578 A ES547578 A ES 547578A ES 8605374 A1 ES8605374 A1 ES 8605374A1
Authority
ES
Spain
Prior art keywords
dynorubicine
subyl
virals
doxorubicin
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547578A
Other languages
English (en)
Spanish (es)
Other versions
ES547578A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of ES547578A0 publication Critical patent/ES547578A0/es
Publication of ES8605374A1 publication Critical patent/ES8605374A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES547578A 1984-10-22 1985-10-03 Un metodo de produccion de una solucion inyectable de un antraciclina glicosido Expired ES8605374A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES547578A0 ES547578A0 (es) 1986-03-16
ES8605374A1 true ES8605374A1 (es) 1986-03-16

Family

ID=10568553

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547578A Expired ES8605374A1 (es) 1984-10-22 1985-10-03 Un metodo de produccion de una solucion inyectable de un antraciclina glicosido

Country Status (35)

Country Link
US (4) US4675311A (OSRAM)
JP (1) JPH0611700B2 (OSRAM)
KR (1) KR920005813B1 (OSRAM)
CN (1) CN85107562B (OSRAM)
AT (1) AT401345B (OSRAM)
AU (1) AU572003B2 (OSRAM)
BE (1) BE903484A (OSRAM)
BG (1) BG60934B2 (OSRAM)
CA (1) CA1248453A (OSRAM)
CH (1) CH667594A5 (OSRAM)
CS (1) CS270421B2 (OSRAM)
DE (1) DE3536896C2 (OSRAM)
DK (1) DK165620C (OSRAM)
ES (1) ES8605374A1 (OSRAM)
FI (2) FI853913A7 (OSRAM)
FR (1) FR2571966B1 (OSRAM)
GB (2) GB8426672D0 (OSRAM)
GR (1) GR852549B (OSRAM)
HK (1) HK94390A (OSRAM)
HU (1) HU197988B (OSRAM)
IE (1) IE56992B1 (OSRAM)
IL (1) IL76732A (OSRAM)
IT (1) IT1186779B (OSRAM)
MY (1) MY103956A (OSRAM)
NL (1) NL191308C (OSRAM)
NO (1) NO170616C (OSRAM)
NZ (1) NZ213885A (OSRAM)
PH (1) PH23982A (OSRAM)
PT (1) PT81347B (OSRAM)
RU (2) RU1836088C (OSRAM)
SE (1) SE467520B (OSRAM)
SG (1) SG80290G (OSRAM)
UA (2) UA19169A (OSRAM)
YU (1) YU46160B (OSRAM)
ZA (1) ZA858033B (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
DK175815B1 (da) * 1986-12-05 2005-03-07 Pharmacia Italia Spa Lagerfaste, sterile, pyrogen-frie, injicerbare anthracyclin-glycosid-oplösninger og fremgangsmåde til deres fremstilling
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
JP2001513078A (ja) 1996-12-30 2001-08-28 バテル・メモリアル・インスティテュート 吸入により新生物を治療する製剤とその方法
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
RU2292216C2 (ru) * 2000-10-31 2007-01-27 Фарма Мар, С.А. Кахалалид f
CN100346784C (zh) 2002-02-22 2007-11-07 先灵公司 抗肿瘤剂,特别是替莫唑胺的药物制剂,其制备方法和用途
EP1474995B1 (en) * 2003-05-06 2012-11-14 Gumlink A/S A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
EP1638509B1 (en) * 2003-07-02 2015-12-30 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
ES2344899T3 (es) * 2003-09-25 2010-09-09 Astellas Pharma Inc. Agente antitumoral que comprende un inhibidor de histona desacetilasa y un inhibidor de topoisomerasa ii.
RU2262923C2 (ru) * 2003-12-25 2005-10-27 Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации Иммобилизованная форма доксорубицина
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
BRPI0613034A8 (pt) 2005-07-14 2018-01-02 Lipothera Inc formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo.
DE06848583T1 (de) * 2005-12-13 2011-03-17 Solux Corporation, San Diego Verfahren zur herstellung von 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
CA2687291A1 (en) * 2007-05-16 2008-11-20 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
EP2184066B1 (en) * 2007-09-04 2013-11-06 Meiji Seika Pharma Co., Ltd. Injection, injection solution and injection kit preparation
AU2008315718A1 (en) * 2007-10-26 2009-04-30 Pfizer Products Inc. Idarubicin for the treatment of lymphoma in a dog
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SG2014014351A (en) * 2010-01-15 2014-07-30 Lithera Inc Lyophilized cake formulations
WO2012074856A2 (en) 2010-11-24 2012-06-07 Lithera, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
DK2931042T3 (da) 2012-12-13 2021-06-07 Cytrx Corp Anthracyclinformuleringer
US10278981B2 (en) 2013-06-05 2019-05-07 Cytrx Corporation Cytotoxic agents for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
AT380480B (de) * 1982-05-24 1986-05-26 Erba Farmitalia Verfahren zur herstellung von anthracyclinglykosiden
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (OSRAM) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
ZA858033B (en) 1986-06-25
CN85107562B (zh) 1988-06-01
JPH0611700B2 (ja) 1994-02-16
DE3536896C2 (de) 1996-11-14
US5091373A (en) 1992-02-25
JPS61246129A (ja) 1986-11-01
NL191308C (nl) 1995-05-16
IT1186779B (it) 1987-12-16
FR2571966A1 (fr) 1986-04-25
ES547578A0 (es) 1986-03-16
PH23982A (en) 1990-02-09
UA19169A (uk) 1997-12-25
FI853913A0 (fi) 1985-10-08
IE852593L (en) 1986-04-22
NO170616C (no) 1992-11-11
UA34419C2 (uk) 2001-03-15
RU2101018C1 (ru) 1998-01-10
SE8504945D0 (sv) 1985-10-21
PT81347B (pt) 1987-11-11
NL191308B (nl) 1994-12-16
DK165620B (da) 1992-12-28
HU197988B (en) 1989-07-28
IT8522507A0 (it) 1985-10-16
FR2571966B1 (fr) 1988-04-15
US4840938A (en) 1989-06-20
GB2165751B (en) 1988-08-17
SG80290G (en) 1990-11-23
BG60934B2 (bg) 1996-06-28
PT81347A (en) 1985-11-01
CH667594A5 (de) 1988-10-31
GB2165751A (en) 1986-04-23
KR860003014A (ko) 1986-05-19
CS270421B2 (en) 1990-06-13
NO854194L (no) 1986-04-23
IL76732A0 (en) 1986-02-28
AU4880585A (en) 1986-05-01
IE56992B1 (en) 1992-02-26
CS756585A2 (en) 1989-11-14
GB8525709D0 (en) 1985-11-20
DK481585A (da) 1986-04-23
BE903484A (fr) 1986-04-21
DK165620C (da) 1993-06-01
GB8426672D0 (en) 1984-11-28
DK481585D0 (da) 1985-10-21
IL76732A (en) 1989-07-31
AT401345B (de) 1996-08-26
FI853913A7 (fi) 1986-04-23
GR852549B (OSRAM) 1986-02-24
ATA303285A (de) 1996-01-15
FI86252B (fi) 1992-04-30
SE8504945L (sv) 1986-04-23
MY103956A (en) 1993-10-30
YU164485A (en) 1987-10-31
CN85107562A (zh) 1986-07-23
DE3536896A1 (de) 1986-04-24
YU46160B (sh) 1993-05-28
FI86252C (fi) 1992-08-10
RU1836088C (ru) 1993-08-23
US4675311A (en) 1987-06-23
FI854035L (fi) 1986-04-23
AU572003B2 (en) 1988-04-28
CA1248453A (en) 1989-01-10
SE467520B (sv) 1992-08-03
HUT40759A (en) 1987-02-27
KR920005813B1 (ko) 1992-07-20
US5091372A (en) 1992-02-25
NL8502869A (nl) 1986-05-16
FI854035A0 (fi) 1985-10-16
HK94390A (en) 1990-11-23
NZ213885A (en) 1988-05-30
NO170616B (no) 1992-08-03

Similar Documents

Publication Publication Date Title
ES8605374A1 (es) Un metodo de produccion de una solucion inyectable de un antraciclina glicosido
Bertazzoli et al. Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats
RU2000131681A (ru) Тритерпеновые композиции и способы их применения
FR2325659A1 (fr) Nouvelles glycosides antitumorales de la serie anthracycline et procede pour leur preparation
RU2100366C1 (ru) Антрациклиновые гликозиды и их фармацевтически приемлемые кислотно-аддитивные соли, способ их получения, дииодопромежуточное соединение и способ его получения
NO170913C (no) Fremgangsmåte for fremstilling av en injiserbar opplösning inneholdende etantitumorantracyklin-glykosid
AU6327073A (en) Method forthe removal of organic substances from sodium aluminate solution
BE841415A (fr) Procede de preparation d'ethers cellulosiques absorbant de l'eau
GB1123288A (en) Improvements in or relating to new triterpene derivatives, process for preparing same, and applications thereof
BE820324A (fr) Ethers 2-carbalcoxy-amino-benzimidazolyl-5(6)-amino-phenyliquesa action anthelmintique et leur procede de preparation
JPS579725A (en) Method of promoting oral absorption of glycoside and related antibiotics
IT1009544B (it) Procedimento per la eliminazione delle tensioni in pietre dure per il montaggio di perni in orologeria costituite da cristalli di ossidi metallici lavorate con elevata sol lecitazione del materiale
AU624839B2 (en) Morpholino derivatives of rhodomycins, processes for their preparation and their use
FR2551057B1 (fr) Nouveaux aglycones utiles pour la preparation des antibiotiques et des antitumoraux de la serie des anthracyclines et leurs procedes de preparation
JPS6426590A (en) Anthracycline antibiotic having antitumor action
LING et al. COLLAGEN AND GROUND SUBSTANCE IN THE PROCESS OF FRACTURE HEALING (AN EXPERIMENTAL STUDY)
LI et al. Effects of Panax notoginseng saponins on acute cerebral ischemia
IT1050358B (it) Procedimento per la preparazione di derivati del 5 idrossi 2 carrossi cromone
BE805999A (fr) Procede de preparation d'ethers en 4 d'acides 3-amino-5- sulfamoyl-benzoiques
LIU THE CHANGE IN EPITHELIUM OF DUODENAL ULCER DURING HEALING PROCESS
SE8300324D0 (sv) Daunorubicin och doxorubicin-analoger, deras framstellning och anvendning
IT1109045B (it) Procedimento chimico per l'isolamento della specie botanica digitalis lanata del glicoside lanatoside c e sua trasformazione in desacetil-lanatoside c(deslanoside)
SHI RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS
CHUN et al. Hyperbaric oxygen therapy in systemic scleroderma
BE813605A (fr) Procede de preparation de polyethers purs

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20051123